ASPIRE BIOPHARMA HOLDINGS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $293.7K | $293.2K | — |
| FY2022 | $11.1M | $300.2M | $497.3K |
| FY2023 | $403.3K | $20.0M | $11.2K |
| FY2024 | $1.7M | $148.0K | $3.6K |
| FY2025 | $7.7M | $1.3M | $1.0M |
Rule No. 1 : Never lose money. Rule No. 2 : Never forget Rule No. 1.